Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
FTAAU FTAC Athena Acquisition Corp
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund
LGO Largo Inc
ONTO Onto Innovation Inc
OFED Oconee Federal Financial Corp
WKEY Wisekey International Holding AG
FPH Five Point Holdings LLC
FATE Fate Therapeutics Inc
MCD McDonald's Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

Closing Price
$146.28
Day's Change
-1.12 (-0.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
147.68
Day's Low
146.02
Volume
(Light)
Volume:
4,591,481

10-day average volume:
6,392,098
4,591,481

Is Berkshire Hathaway a Value Stock?

11:46 am ET January 13, 2023 (Zacks) Print

  • (0:45) - Value Stocks Back In Favor: Should You jump On The Warren Buffett Bandwagon?
  • (6:00) - Ark Invest vs Berkshire Hathaway: What Fits Best Into Your Portfolio?
  • (21:00) - Episode Roundup: BRKB, ARKK, AAPL, BAC, KO, AXP, TSM, CVX, EXAS, ZM, TSLA
  •                 Podcast@Zacks.com

 

Welcome to Episode #312 of the Value Investor Podcast.

Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.

With value stocks out performing in 2022, value investing has come back into favor.

And that means the cult of Warren Buffett, and Berkshire Hathaway, is back. At the end of 2022, there was a chart making the rounds on Twitter that compared Cathie Wood’s ARK Innovation performance over the last 5 years with Berkshire Hathaway’s.

As you might have guessed, Berkshire Hathaway is outperforming thanks to ARKK’s terrible 2022. Over the last 5 years, Berkshire Hathaway is up 76.3% while ARKK is down 18.9%.

Meanwhile, many investors are diving into Berkshire Hathaway’s stock in search of safety. Over the last three months, Berkshire’s B shares are up 19.3% versus the S&P 500’s gain of 10.5%.

But is Berkshire Hathaway itself even a value stock?

Should value investors be investing in the stock, and its large holdings?

Is there Value in Berkshire Hathaway?

1.       Berkshire Hathaway (BRK.B)

Berkshire Hathaway is a large cap holding company that owns dozens of businesses, cash and equity investments. Reminder: it’s not a mutual fund or an ETF fund. It’s a corporation with Warren Buffett as Chairman and CEO.

Berkshire Hathaway trades with a forward P/E of 19, which is more expensive than the S&P 500 and is not in the normal range for most value investors. Tracey usually looks for companies trading under 15.

What about its PEG ratio? Berkshire Hathaway has a PEG of 2.7, which does not indicate value either. A PEG under 1.0 indicates a company has growth and value.

However, Berkshire does have a P/B ratio of 1.5, which is under 3.0, and indicates value.

Is a low P/B ratio enough for value investors or should they wait for a sell-off in the Berkshire Hathaway shares?

2.       Apple Corp. AAPL

Apple is Berkshire’s largest equity holding. It was cheap when Buffett first bought it in 2016, with a forward P/E of around 10.

But in 2023, it is trading at 21x, which is much higher than the S&P 500 which is trading around 18. Apple has a PEG of 1.7.

Additionally, earnings are expected to rise just 1% in fiscal 2023 so there isn’t much growth there either.

Should value investors take a pass on Apple?

3.       Bank of America BAC

Bank of America is Berkshire’s second largest holding, and has been for several years. Warren Buffett has been patient with Bank of America, even while selling many of his other bank stocks.

Shares of Bank of America are down 30% in the last year. It’s cheap with a forward P/E of 9.5. But with banks, investors should also look at P/B ratio. Bank of America’s is 1.15. With banks, a P/B ratio near 1.0 indicates there’s value.

Should investors join Buffett and add Bank of America to their own short list?

4.       Chevron Corp. CVX

Chevron suddenly became the third largest position in Berkshire’s portfolio, at 8%, last year when Buffett went all in on the energy stocks.

Chevron shares surged in 2022, rising 36.9% as energy was the best performing sector for the second year in a row. But it remains cheap as earnings have also risen. Chevron is trading with a forward P/E of just 10.8.

It’s yielding 3.2% now.

Should you follow Buffett into the energy trade, or is it too late to jump into Chevron?

5.       The Coca-Cola Company KO

Coca-Cola has been in the Berkshire portfolio since the first quarter of 2001. Berkshire has held it through the Great Recession and the pandemic. It’s still the fourth largest position in the portfolio.

Coca-Cola shares are up 25% over the last 2 years, versus just 5.4% for the S&P 500.

But shares aren’t cheap. It trades with a forward P/E of 24.4. And Coca-Cola has a PEG ratio of 3.9.

Is Coca-Cola too expensive for value investors in 2023?

What Else Should You Know About Berkshire Hathaway to Start 2023?

Listen to this week’s podcast to find out.

[In full disclosure, Tracey owns BAC in Zacks Value Investor portfolio.]

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Bank of America Corporation (BAC): Free Stock Analysis Report
 
Apple Inc. (AAPL): Free Stock Analysis Report
 
Chevron Corporation (CVX): Free Stock Analysis Report
 
CocaCola Company The (KO): Free Stock Analysis Report
 
Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.